Form 4: CHEMED VP Hutton Acquires 6,338 Stock Options

CHEMED Corp. Vice President Thomas C. Hutton acquired 6,338 stock options with an exercise price of $443.79, vesting annually starting October 21, 2026.

Summary

• Thomas C. Hutton, a Director and Vice President of CHEMED Corp., acquired 6,338 derivative securities in the form of stock options.
• The transaction date for this acquisition was October 21, 2025.
• Each stock option has an exercise price of $443.79.
• The options will vest in three equal annual installments, with the first installment commencing on October 21, 2026.
• The expiration date for these stock options is October 21, 2030.
• Following this transaction, Thomas C. Hutton beneficially owns a total of 26,718 derivative securities.

Sentiment

Score: 7

Explanation: The acquisition of stock options by a key executive is generally viewed positively as it aligns management's interests with shareholders, incentivizing long-term growth and performance. It is a routine compensation event, not indicative of extraordinary news, hence a moderately positive score.

Positives

• The acquisition of stock options by a Vice President and Director aligns management's financial interests with those of shareholders, incentivizing long-term company performance.
• The vesting schedule encourages executive retention and sustained focus on future growth.

Future Outlook

The stock options are structured to vest in three equal annual installments commencing October 21, 2026, indicating a future incentive for long-term performance and retention of the executive.

Industry Context

This transaction represents a standard component of executive compensation packages within the healthcare services industry, aiming to align management incentives with shareholder interests through equity ownership and long-term performance goals.

Comparison to Industry Standards

• The grant of stock options to executives is a common practice across various industries, including healthcare services, to incentivize long-term performance and retention.
• While specific terms like exercise price, number of options, and vesting schedules vary by company and executive role, the underlying mechanism of equity-based compensation is consistent with global benchmarks for executive incentive programs.

Stakeholder Impact

• Shareholders: The grant of stock options to a director and vice president can enhance alignment between management and shareholder interests, potentially leading to improved long-term company performance.
• Employees: While not directly impacting all employees, executive compensation structures can influence overall company culture and incentive programs.

Next Steps

• The stock options will begin vesting in three equal annual installments starting October 21, 2026.

Key Dates

Keywords

CHEMED Corp, CHE, Stock Options, Executive Compensation, Insider Transaction, Form 4, Equity Grant, Director Compensation, Vice President